Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$106,221,270
+$17,906,846 QoQ
Shares Held
422,116
+4.0% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
1.45%
of 13F equity value
Holder Rank
#247
of 4,153 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NewEdge Wealth, LLC holds $502,588,092 across 13 Drug Manufacturers - General names. ABBV ranks #1 (21.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
422,116 | $106,221,270 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
754,019 | $95,262,760 | |
| 3 | NVS |
Novartis AG
|
579,486 | $90,817,045 | |
| 4 | LLY |
ELI LILLY & Co
|
64,986 | $77,946,164 | |
| 5 | JNJ |
Johnson & Johnson
|
255,223 | $64,818,985 | |
| 6 | AMGN |
Amgen Inc
|
110,074 | $39,859,996 | |
| 7 | MRK |
Merck & Co., Inc.
|
64,900 | $8,339,650 | |
| 8 | AZN |
Astrazeneca PLC
|
33,124 | $6,280,972 |
All Filings in ABBV
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $106,221,270 | 422,116 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $88,314,424 | 406,062 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $90,865,217 | 397,677 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $70,509,023 | 304,522 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $42,536,307 | 229,158 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $44,533,895 | 212,552 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $36,095,134 | 203,124 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $37,264,870 | 188,702 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $19,783,802 | 115,344 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $8,052,644 | 44,221 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $7,188,283 | 46,385 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $13,024,415 | 87,377 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $10,603,520 | 78,702 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $10,499,136 | 65,879 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $10,365,665 | 64,140 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,798,137 | 58,104 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,890,172 | 58,045 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $5,508,335 | 33,979 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $405,929 | 2,998 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $258,780 | 2,399 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $261,324 | 2,320 | Shares | Sole | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||